NO323856B1 - Dermale anestetika, deres fremstilling, sammensetninger inneholdende dem og deres anvendelse. - Google Patents

Dermale anestetika, deres fremstilling, sammensetninger inneholdende dem og deres anvendelse. Download PDF

Info

Publication number
NO323856B1
NO323856B1 NO20016037A NO20016037A NO323856B1 NO 323856 B1 NO323856 B1 NO 323856B1 NO 20016037 A NO20016037 A NO 20016037A NO 20016037 A NO20016037 A NO 20016037A NO 323856 B1 NO323856 B1 NO 323856B1
Authority
NO
Norway
Prior art keywords
compound
hydrogen
formula
piperidine
composition
Prior art date
Application number
NO20016037A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016037D0 (no
NO20016037L (no
Inventor
Jan L Chen
Gunnar A K Aberg
George L Wright
Original Assignee
Bridge Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bridge Pharma Inc filed Critical Bridge Pharma Inc
Publication of NO20016037D0 publication Critical patent/NO20016037D0/no
Publication of NO20016037L publication Critical patent/NO20016037L/no
Publication of NO323856B1 publication Critical patent/NO323856B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20016037A 1999-06-10 2001-12-10 Dermale anestetika, deres fremstilling, sammensetninger inneholdende dem og deres anvendelse. NO323856B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13835399P 1999-06-10 1999-06-10
US17926700P 2000-01-31 2000-01-31
PCT/US2000/015490 WO2000076510A1 (en) 1999-06-10 2000-06-06 Dermal anesthetic agents

Publications (3)

Publication Number Publication Date
NO20016037D0 NO20016037D0 (no) 2001-12-10
NO20016037L NO20016037L (no) 2002-02-11
NO323856B1 true NO323856B1 (no) 2007-07-16

Family

ID=26836123

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016037A NO323856B1 (no) 1999-06-10 2001-12-10 Dermale anestetika, deres fremstilling, sammensetninger inneholdende dem og deres anvendelse.

Country Status (18)

Country Link
US (1) US6413987B1 (OSRAM)
EP (1) EP1185267B1 (OSRAM)
JP (1) JP2003501469A (OSRAM)
CN (1) CN1355700A (OSRAM)
AT (1) ATE335482T1 (OSRAM)
AU (1) AU777517B2 (OSRAM)
BR (1) BR0011028A (OSRAM)
CA (1) CA2376819C (OSRAM)
CY (1) CY1105721T1 (OSRAM)
DE (1) DE60029954T2 (OSRAM)
DK (1) DK1185267T3 (OSRAM)
ES (1) ES2267546T3 (OSRAM)
IL (2) IL146190A0 (OSRAM)
MX (1) MXPA01012632A (OSRAM)
NO (1) NO323856B1 (OSRAM)
NZ (1) NZ515143A (OSRAM)
PT (1) PT1185267E (OSRAM)
WO (1) WO2000076510A1 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1321139T1 (sl) * 2001-12-21 2007-02-28 Chiesi Farma Spa 2-indanilamino-derivati za zdravljenje kronicne, akutne ali vnetne bolecine
PL376890A1 (pl) * 2002-11-26 2006-01-09 Maruishi Pharmaceutical Co., Ltd. Pochodne izoindoliny
WO2006037047A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
US7718674B2 (en) 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
US20090137628A1 (en) * 2005-09-23 2009-05-28 Bridge Pharma, Inc. Formulations of Indanylamines and the Use Thereof as Local Anesthetics and as Medication for Chronic Pain
US20110218218A1 (en) * 2005-09-23 2011-09-08 Bridge Pharma, Inc. Formulations Of Indanylamines And The Use Thereof As Local Anesthetics And As Medication For Chronic Pain
CA2655809C (en) 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds
DK2244737T3 (da) * 2008-01-22 2019-07-08 Univ Texas Flygtige anæstetiske sammensætninger omfattende ekstraktionsopløsningsmidler til regional anæstesi og/eller smertelindring
BR112013020874A2 (pt) * 2011-02-18 2019-05-21 Endo Pharmaceuticals Inc. composto, regime, método para a preparação do referido composto, e, uso de um composto
US8809372B2 (en) 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
US8685418B2 (en) 2011-10-24 2014-04-01 Endo Pharmaceuticals Inc. Cyclohexylamines
US9044482B2 (en) 2012-08-15 2015-06-02 Asana Biosciences, Llc Use of aminoindane compounds in treating overactive bladder and interstitial cystitis
EA201891225A1 (ru) 2015-11-23 2018-11-30 Грейс Терапьютикс Ллк Пленкообразующий спрей для местного применения
JP7656266B2 (ja) 2018-12-19 2025-04-03 グレイス セラピューティクス、インコーポレイテッド 鼻腔内リドカインの治療用組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE760018A (fr) * 1969-12-19 1971-06-08 Christiaens Sa A Nouveau derives du 2-amino-indane, leur preparation et leur utilisation
US3923813A (en) 1969-12-19 1975-12-02 Christiaens Sa A Derivatives of 2-aminoindanes
AR206505A1 (es) * 1972-09-18 1976-07-30 Christiaens Sa A Procedimiento para obtener nuevos derivados de n-fenil-n-aminoalquil-2-aminoindano
ZA738419B (en) 1972-11-06 1974-09-25 Christiaens Sa A New derivatives of 2-aminoindane,the preparation and use thereof
GB1462036A (en) * 1973-02-05 1977-01-19 Manuf Prod Pharma Aminoindane derivatives
GB1468347A (en) * 1973-03-02 1977-03-23 Christiaens Sa A Aminoindanes

Also Published As

Publication number Publication date
MXPA01012632A (es) 2004-03-19
US6413987B1 (en) 2002-07-02
CN1355700A (zh) 2002-06-26
CA2376819A1 (en) 2000-12-21
NO20016037D0 (no) 2001-12-10
CA2376819C (en) 2008-09-02
DK1185267T3 (da) 2006-12-11
EP1185267A4 (en) 2003-09-03
WO2000076510A9 (en) 2002-07-04
CY1105721T1 (el) 2010-12-22
JP2003501469A (ja) 2003-01-14
WO2000076510A1 (en) 2000-12-21
DE60029954T2 (de) 2007-03-08
DE60029954D1 (de) 2006-09-21
EP1185267A1 (en) 2002-03-13
BR0011028A (pt) 2002-02-19
EP1185267B1 (en) 2006-08-09
IL146190A0 (en) 2002-07-25
AU5596300A (en) 2001-01-02
NZ515143A (en) 2004-05-28
ES2267546T3 (es) 2007-03-16
AU777517B2 (en) 2004-10-21
IL146190A (en) 2008-11-03
PT1185267E (pt) 2006-12-29
ATE335482T1 (de) 2006-09-15
NO20016037L (no) 2002-02-11

Similar Documents

Publication Publication Date Title
NO323856B1 (no) Dermale anestetika, deres fremstilling, sammensetninger inneholdende dem og deres anvendelse.
CN112574098B (zh) 一种酰胺化合物及其制备方法和用途
KR102173572B1 (ko) 아미노인단 화합물 및 통증 치료에서 그것의 용도
US20230250098A1 (en) Kratom opioid derivatives for the treatment of alcohol use disorder
JPS58501724A (ja) ２−ヒドロキシプロピルアミンアリ−ルエステル誘導体
JP3939369B2 (ja) β３ −アドレナリン作動薬として作用する｛（７Ｓ）−７−［（２Ｒ）−２−（３−クロロフェニル）−２−ヒドロキシエチルアミノ］−５，６，７，８−テトラヒドロナフタレン−２−イルオキシ）酢酸及びその薬学的に許容されうる塩、並びにそれらが存在する薬学的組成物及び研究室用試薬
WO1996031470A1 (en) Novel heterocyclic compounds
NO310614B1 (no) Nye [(3-alkoksyfenoksy)-etyl]-dialkylaminderivater, farmasöytisk preparat, anvendelse av derivatene til fremstillingav lokalanestetika, og fremgangsmåte for deres fremstilling
NO150734B (no) Fremgangsmaate ved produksjon av olje eller gass gjennom en broenn som strekker seg gjennom en olje- eller gassholdig formasjon
TR201802766T4 (tr) Alfa adrenerjik kaynaklı rahatsızlıkların tedavisi için bileşik.
US7592458B2 (en) Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain
US4590210A (en) Compositions for treatment of ocular hypertension
EP1658847A2 (en) Indane derivatives as dermal anesthetic agents
NO137752B (no) Analogifremgangsm}ter til fremstilling av forbindelser med antiarrytmisk virkning
US5140022A (en) 3-acyclic or cyclicaminomethyl-17a-lower-alkyl-17a-aza-d-homo-5-alpha-androstanes
MXPA01001461A (es) Metabolitos de difenhidramina no sedantes.
US4088783A (en) Novel optically active m-acyloxy-α-[(methylamino)methyl]benzyl alcohols and the pharmaceutically acceptable acid addition salts thereof
NO139733B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av metylamin
US4558066A (en) Treatment and prevention of ocular hypertension
WO1996031500A1 (en) Novel heterocyclic compounds
NO863448L (no) Fremgangsmaate for fremstilling av oculoselektive beta-blokkere.
US20110124685A1 (en) Anesthetic Compounds
US3376192A (en) 10, 11-dihydro-5h-dibenzo[a, d]cycloheptenes as local anesthetics
WO1996031479A1 (en) Novel heterocyclic compounds
WO1996031472A1 (en) Novel heterocyclic compounds